Virios Therapeutics Inc

NASDAQ:VIRI   2:01:46 PM EDT
5.83
+0.33 (+6.00%)
Earnings Announcements

Virios Therapeutics Announces Second Quarter 2021 Financial Results And Provides Corporate Update

Published: 08/12/2021 11:13 GMT
Virios Therapeutics Inc (VIRI) - Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update.
Q2 Loss per Share $0.51.
Believes It Will Have Sufficient Resources to Fund Its Planned Operations Through End of 2022.
Top Line Results of Fortress Phase 2b Clinical Trial Are Expected in Mid-2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.